Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 1.48 is 26% below its estimated 1-year average of 1.99, near the low end of its estimated 1-year range (1.09–5.74).
As of 2026-10-06T14:16:20.641Z.
Calculation as of: 2026-10-06T14:16:20.641Z.
Quote observation: 2026-10-06T14:12:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4cebeea1a9b4d788b134268ad244658713bcf5e38577c227b803d15950d20ec6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
1.48
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.44
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-39.22%
vs the sector median at left
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$5.80M
PB Ratio
1.48
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.10M
PB Ratio
0.82
TTM Avg
0.63
3Y Avg
68.58
5Y Avg
372.16
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $5.80M | 1.48 | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.92M | 0.86 | 0.64 | 0.72 | 1.04 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.98M | 0.00 | 0.65 | 0.94 | 1.03 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.55M | 0.68 | 0.99 | 5.06 | 4.61 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 0.82 | 0.63 | 68.58 | 372.16 |
| Femasys Inc. (FEMY)vs › | $6.13M | 1.52 | 4.42 | 4.61 | 3.18 |
| Biomerica, Inc. (BMRA)vs › | $6.22M | 2.36 | 1.80 | 7.87 | 19.88 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.35M | N/A | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.33M | 0.92 | 2.38 | 1.71 | 5.62 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.29M | 1.08 | 28.43 | 28.43 | 28.43 |
At 1.48, P/B is below its estimated 1-year median — higher than 23% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
1.09
median
1.99
estimated 1-year high
5.74
P/B Ratio
1.48
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 1.54 |
| 2026-10-02 | 1.65 |
| 2026-10-01 | 1.74 |
| 2026-09-30 | 1.56 |
| 2026-09-29 | 1.37 |
| 2026-09-28 | 1.33 |
| 2026-09-25 | 1.28 |
| 2026-09-24 | 1.30 |
| 2026-09-23 | 1.28 |
| 2026-09-22 | 1.36 |
| 2026-09-21 | 1.29 |
| 2026-09-18 | 1.22 |
| 2026-09-17 | 1.18 |
| 2026-09-16 | 1.09 |
| 2026-09-15 | 2.00 |
| 2026-09-14 | 2.18 |
| 2026-09-11 | 2.15 |
| 2026-09-10 | 2.05 |
| 2026-09-09 | 1.99 |
| 2026-09-08 | 2.13 |
| 2026-09-04 | 2.16 |
| 2026-09-03 | 2.01 |
| 2026-09-02 | 1.90 |
| 2026-09-01 | 1.98 |
| 2026-08-31 | 1.99 |
| 2026-08-28 | 2.05 |
| 2026-08-27 | 2.14 |
| 2026-08-26 | 2.01 |
| 2026-08-25 | 1.99 |
| 2026-08-24 | 1.86 |
| 2026-08-21 | 1.97 |
| 2026-08-20 | 1.92 |
| 2026-08-19 | 1.99 |
| 2026-08-18 | 2.03 |
| 2026-08-17 | 1.99 |
| 2026-08-14 | 2.05 |
| 2026-08-13 | 2.12 |
| 2026-08-12 | 2.05 |
| 2026-08-11 | 2.04 |
| 2026-08-10 | 2.07 |
| 2026-08-07 | 2.27 |
| 2026-08-06 | 2.29 |
| 2026-08-05 | 2.44 |
| 2026-08-04 | 2.03 |
| 2026-08-03 | 1.97 |
| 2026-07-31 | 1.99 |
| 2026-07-30 | 1.82 |
| 2026-07-29 | 2.19 |
| 2026-07-28 | 2.27 |
| 2026-07-27 | 2.46 |
| 2026-07-24 | 2.28 |
| 2026-07-23 | 2.26 |
| 2026-07-22 | 2.25 |
| 2026-07-21 | 2.61 |
| 2026-07-20 | 2.61 |
| 2026-07-17 | 2.71 |
| 2026-07-16 | 2.74 |
| 2026-07-15 | 2.87 |
| 2026-07-14 | 2.79 |
| 2026-07-13 | 2.95 |
| 2026-07-10 | 3.39 |
| 2026-07-09 | 3.61 |
| 2026-07-08 | 3.47 |
| 2026-07-07 | 3.92 |
| 2026-07-06 | 3.86 |
| 2026-07-02 | 3.94 |
| 2026-07-01 | 4.07 |
| 2026-06-30 | 4.50 |
| 2026-06-29 | 3.04 |
| 2026-06-26 | 3.64 |
| 2026-06-25 | 3.86 |
| 2026-06-24 | 3.92 |
| 2026-06-23 | 2.69 |
| 2026-06-22 | 2.68 |
| 2026-06-18 | 2.98 |
| 2026-06-17 | 3.59 |
| 2026-06-16 | 3.60 |
| 2026-06-15 | 5.74 |
| 2026-06-12 | 2.71 |
| 2026-06-11 | 1.64 |
| 2026-06-10 | 1.54 |
| 2026-06-09 | 1.62 |
| 2026-06-08 | 1.71 |
| 2026-06-05 | 1.66 |
| 2026-06-04 | 1.86 |
| 2026-06-03 | 1.93 |
| 2026-06-02 | 1.83 |
| 2026-06-01 | 1.82 |
| 2026-05-29 | 1.64 |
| 2026-05-28 | 2.25 |
| 2026-05-27 | 1.51 |
| 2026-05-26 | 1.34 |
| 2026-05-22 | 1.47 |
| 2026-05-21 | 1.52 |
| 2026-05-20 | 1.45 |
| 2026-05-19 | 1.47 |
| 2026-05-18 | 1.51 |
| 2026-05-15 | 1.51 |
| 2026-05-14 | 1.46 |
| 2026-05-13 | 1.43 |
| 2026-05-12 | 1.35 |
| 2026-05-11 | 1.47 |
| 2026-05-08 | 1.53 |
| 2026-05-07 | 1.44 |
| 2026-05-06 | 1.44 |
| 2026-05-05 | 1.45 |
| 2026-05-04 | 1.43 |
| 2026-05-01 | 1.38 |
| 2026-04-30 | 1.38 |
| 2026-04-29 | 1.47 |
| 2026-04-28 | 1.56 |
